• Business
  • Entertainment
  • Health
  • News
  • Sport
  • Tech
  • World
Newsy Today
news of today
Home - Viruses
Tag:

Viruses

Health

Dangerous Tick-Borne Virus Spreading Across the U.S.

by Chief Editor June 29, 2026
written by Chief Editor

The Powassan virus, a rare tick-borne disease, has reached a record high in the United States with 76 diagnosed cases reported in 2025, according to the Centers for Disease Control and Prevention (CDC). Unlike more common tick-borne illnesses like Lyme disease, Powassan can transmit to a human host in as little as 15 minutes after a bite, posing a significant public health challenge.

The Origins and Evolution of Powassan Virus

Medical history traces the Powassan virus back to a 1958 case involving a 4-year-old boy named Lincoln Byers. According to the Boston Globe, Byers lived in Canada and suffered from a mysterious, fatal condition that doctors could not identify at the time. Researchers eventually identified a tick carrying the virus on a dead squirrel, confirming the disease’s origin.

For decades, the virus remained an obscure medical anomaly. However, recent data shows a stark shift. Before the record-breaking 76 cases in 2025, the U.S. typically saw only seven to eight diagnoses annually. Public health officials note that the virus is most prevalent from late spring through mid-fall, aligning with peak tick activity and increased outdoor recreation.

Why Powassan’s Transmission Speed Is Unique

The primary concern for clinicians is the speed at which the virus moves from tick to human. Dr. Jorge P. Parada, a medical advisor at the National Pest Management Association in Chicago, told Fox News Digital that the 15-minute transmission window makes Powassan uniquely dangerous compared to other pathogens. By contrast, Lyme disease typically requires an attachment time of 36 to 48 hours to transmit.

Dr. Marc Siegel, a medical analyst for Fox News, confirmed this rapid transmission profile. He noted that the virus carries an incubation period of one to four weeks before a patient begins to show clinical symptoms.

Did you know? While Powassan is considered rare, it poses clinical concern. Approximately 10% of Powassan cases involving severe neurological disease are fatal.

Symptoms and Clinical Risks

Initial symptoms of the Powassan virus include fever, headache, vomiting, and weakness, according to the CDC. However, some individuals remain asymptomatic throughout the course of the infection. In more severe cases, the virus can progress to life-threatening conditions such as encephalitis—inflammation of the brain—and meningitis, which involves inflammation of the spinal cord membranes.

Advanced clinical signs include:

  • Confusion
  • Loss of coordination
  • Difficulty speaking
  • Seizures

Currently, there are no specific medications or vaccines available to treat or prevent the virus. Clinical management is limited to supportive therapy, which may include intravenous fluids and respiratory support. While the risk exists for all, children, older adults, and those who are immunocompromised are at the highest risk for severe complications.

Frequently Asked Questions

How is the Powassan virus transmitted?

The virus is primarily transmitted to humans through the bite of an infected woodchuck tick or deer tick.

Frequently Asked Questions

What is the treatment for Powassan?

There is no specific vaccine or medication to treat the virus. Clinical care is limited to supportive therapy, such as intravenous fluids and respiratory support.

How does Powassan compare to Lyme disease?

Powassan transmits much faster (within 15 minutes) than Lyme disease (36–48 hours).

When are ticks most active?

Tick populations and the risk of infection are highest from late spring through mid-fall.


Stay informed on the latest developments in public health by subscribing to our newsletter. Have questions about tick safety or recent health trends? Join the conversation in the comments section below.

June 29, 2026 0 comments
0 FacebookTwitterPinterestEmail
Health

AI-Designed Universal Vaccine Shows Promise

by Chief Editor June 26, 2026
written by Chief Editor

Researchers have successfully tested an artificial intelligence-designed vaccine, pEVAC-PS, which demonstrated safety and tolerability in a Phase 1 clinical trial of 39 healthy adults. Developed by researchers affiliated with the University of Southampton, the University of Cambridge, and DIOSynVax Ltd, the DNA-based vaccine uses a synthetic “super-antigen” to target a broad range of coronaviruses, including SARS-CoV-2 and related bat coronaviruses, potentially providing protection against future variants before they emerge.

How does AI-designed vaccination differ from traditional methods?

Traditional vaccines typically target a single viral strain, requiring scientists to reformulate the product as the virus mutates. In contrast, pEVAC-PS utilizes AI-powered computer modeling to identify structural features common to entire families of viruses. According to researchers at the University of Cambridge, this approach trains the immune system to recognize these shared characteristics. The vaccine aims to provide cross-protection against existing coronaviruses and those that have not yet spilled over into humans.

How does AI-designed vaccination differ from traditional methods?
Did you know?

The pEVAC-PS vaccine is administered through a needle-free intradermal injection system. According to Healthline, this delivery method could reduce the need for specialized equipment while lowering the risk of needle-related injuries and infections.

Why is this approach considered “future-proof”?

Current vaccine development is often reactive, meaning it lags behind the rapid evolution of viral pathogens. Saul Faust from the University of Southampton, the trial’s chief investigator, noted that by the time traditional vaccines are rolled out, they may be poorly matched to circulating strains. Faust stated that this new class of universal vaccines is “future-proofed,” designed to protect against multiple variants simultaneously. By shifting from a reactive model to a proactive one, developers hope to prevent future lockdowns and mitigate economic damage by preparing for viral threats before they trigger an outbreak.

What are the next steps for pEVAC-PS?

While the initial results are promising, the study was a small Phase 1 clinical trial designed primarily to evaluate safety, not effectiveness. Larger studies will be needed to determine whether the vaccine can prevent infection or illness in people.

UKCRFN Vaccine Collaboration – Prof Saul Faust #CRFConf22 #SouthamptonCRF

Comparison: Reactive vs. Proactive Vaccine Development

Feature Traditional Vaccines AI-Designed (pEVAC-PS)
Target Single viral strain Broad viral family
Development Reactive to existing strains Proactive/AI-modeled

Frequently Asked Questions

Is the pEVAC-PS vaccine currently available to the public?
No. The vaccine is in the experimental stage and has only completed a small Phase 1 safety trial.

How is this vaccine administered?
It is delivered as a DNA vaccine using a needle-free intradermal injection system.

What types of viruses can this vaccine potentially block?
The vaccine is designed to target coronaviruses, including SARS-CoV-2, the virus that causes SARS, and related bat coronaviruses that could potentially spill over into humans and trigger future outbreaks.


Stay informed on the latest breakthroughs in biotechnology and public health. Subscribe to our newsletter for weekly updates on medical research, or explore our archive of health innovation articles to learn more about how technology is shaping the future of medicine.

June 26, 2026 0 comments
0 FacebookTwitterPinterestEmail
Health

France says cruise ship Andes virus matches known South American viruses

by Chief Editor May 16, 2026
written by Chief Editor

Beyond the MV Hondius: Why Rapid Viral Sequencing is Our Best Defense Against Zoonotic Leaps

The recent health scare aboard the MV Hondius cruise ship serves as a stark reminder of how quickly a localized biological threat can become a global logistical challenge. When a French passenger returned to Paris showing symptoms of the Andes virus, the world held its breath, fearing a mutation that could trigger a wider outbreak. However, the swift response from the Pasteur Institute—fully sequencing the virus to find it matched known South American strains—highlights a critical shift in how we fight emerging infectious diseases.

We are entering an era where the speed of genomic sequencing is the primary line of defense between a contained incident and a public health crisis. By identifying that the virus showed no evidence of increased transmissibility or danger, health authorities were able to move from a state of alarm to a state of managed monitoring.

The “Cruise Ship Effect” and the Future of Travel Health

Cruise ships are essentially floating microcosms. When a zoonotic virus—one that jumps from animals to humans—enters such a high-density environment, the potential for rapid spread is significant. The MV Hondius incident, involving passengers from France, Spain, the UK, and the Netherlands, underscores the necessity for standardized international health protocols.

The "Cruise Ship Effect" and the Future of Travel Health
MV Hondius cruise ship passenger health alert

Future trends suggest a move toward “Bio-Integrated Travel.” We may soon see the implementation of real-time health screening technologies at ports of entry that go beyond simple temperature checks. Imagine wearable biosensors or rapid point-of-care genomic tests that can flag rare pathogens before a passenger even leaves the tarmac or the dock.

Did you know? Hantaviruses are typically transmitted to humans through contact with the urine, feces, or saliva of infected rodents. The Andes virus is particularly noted for its rare ability to spread from person to person in some specific outbreaks, making rapid sequencing essential to determine if a new strain has gained this capability.

Genomic Surveillance: The New Global Radar

The work performed by the Pasteur Institute is a blueprint for future pandemic prevention. By comparing the passenger’s viral sequence to those circulating in South American rodents and humans, scientists could determine that the 3% variation was merely “natural viral variation” rather than a dangerous mutation.

This capability is evolving into a global “Genomic Radar.” Instead of waiting for patients to show up in hospitals, the next frontier is environmental DNA (eDNA) surveillance. By sequencing air and wastewater samples in high-risk transit hubs, health organizations can detect the presence of a virus like the Andes virus before a single human case is even reported.

From Reactive to Predictive Public Health

The transition from reactive medicine (treating the sick) to predictive surveillance (identifying the threat) relies on three pillars:

View this post on Instagram about One Health, Predictive Public Health
From Instagram — related to One Health, Predictive Public Health
  • Open Data Sharing: As Health Minister Stéphanie Rist noted, sharing sequencing data with the international scientific community is vital.
  • Portable Sequencing: The rise of devices like the Oxford Nanopore allows sequencing to happen in the field, not just in elite labs in Paris.
  • AI-Driven Analysis: Artificial intelligence can now predict which mutations are likely to make a virus more transmissible, allowing scientists to create “pre-emptive” diagnostic tools.

The “One Health” Approach: Connecting Animals, Humans, and Planet

The Andes virus outbreak isn’t just a medical issue; it’s an environmental one. The “One Health” approach recognizes that human health is inextricably linked to the health of animals and our shared environment. As climate change alters rodent habitats and pushes wildlife into closer contact with human settlements and tourist hubs, the frequency of these “spillover events” is expected to rise.

Hanta Virus death confirmed aboard a cruise ship. Possible Andes virus spreads person to person

To mitigate this, future health strategies will likely integrate veterinary surveillance with human healthcare. By monitoring the viral load in rodent populations in South America, we can predict “hot zones” and issue travel advisories before tourists even board a ship.

Pro Tip for Global Travelers: When visiting ecologically diverse regions, avoid disturbing wildlife and ensure your accommodations are rodent-proof. In areas known for hantaviruses, avoid sweeping dusty areas where rodent droppings may have accumulated, as the virus can become airborne.

Coordinating the Global Response

The MV Hondius case demonstrated a complex web of international coordination, with passengers being ferried to Madrid, Manchester, and Paris. The future of global health security depends on the harmonization of quarantine laws and data-sharing agreements.

We are likely to see the creation of a “Global Pathogen Treaty,” where nations agree to share genomic sequences in real-time in exchange for guaranteed access to vaccines or treatments developed from that data. This would eliminate the political friction that often slows down the response to emerging threats.

Frequently Asked Questions

What is the Andes virus?
It is a strain of hantavirus found primarily in South America. It can cause hantavirus pulmonary syndrome (HPS), a severe respiratory disease.

Frequently Asked Questions
Andes virus lab sequencing microscope

How does viral sequencing help stop an outbreak?
Sequencing allows scientists to read the genetic code of a virus. By comparing it to known strains, they can see if the virus has mutated to become more contagious or resistant to treatment.

Is the current situation with the MV Hondius a pandemic threat?
Based on the findings from the Pasteur Institute, the virus matched known strains and showed no evidence of increased transmissibility, meaning the risk of a wider pandemic from this specific event is low.

What is “zoonosis”?
Zoonosis refers to an infectious disease that has jumped from a non-human animal to humans.

Join the Conversation

Do you think global travel should include mandatory health screenings for rare zoonotic diseases? Or is that an overreach of privacy? Let us know your thoughts in the comments below or subscribe to our newsletter for more deep dives into the future of global health.

Subscribe for Updates

May 16, 2026 0 comments
0 FacebookTwitterPinterestEmail
Health

Early Release – Serologic Surveillance of Highly Pathogenic Avian Influenza Virus Subtype H5 in Wildlife, Northeast Germany, 2023–2025 – Volume 32, Number 5—May 2026 – Emerging Infectious Diseases journal

by Chief Editor April 28, 2026
written by Chief Editor

The Growing Threat of H5 Avian Influenza in Mammals

The landscape of avian influenza has shifted. What were once seasonal outbreaks have evolved into a perpetual presence in Europe, creating a global panzootic that threatens not only domestic and wild birds but an increasing variety of mammals. From terrestrial predators to marine species, the “spillover” of highly pathogenic avian influenza viruses (HPAIV) subtype H5 is no longer a rare occurrence—it is a systemic risk. Although much of the public focus remains on poultry, the interface between birds and mammals is where the most concerning evolutionary leaps occur. Recent data indicates that mammalian infections often stem from direct, alimentary exposure—essentially, mammals eating infected birds. In predatory and scavenging species, this has led to severe neurological symptoms and encephalitis, often resulting in death.

Did you understand? While many infections are fatal, some studies suggest a level of asymptomatic infection, meaning some mammals can survive exposure to HPAIV H5 without showing immediate signs of illness.

Why Carnivores are on the Front Line

Not all mammals are equally at risk. Research conducted in northeast Germany, specifically in the state of Mecklenburg–Western Pomerania, highlights a stark contrast in susceptibility between different animal groups. In a study of hunted game, wild ruminants (herbivores) showed no seropositivity against the virus. In contrast, carnivorous species—including foxes, raccoons, and raccoon dogs—showed significant levels of H5-specific antibodies, with seropositivity rates ranging from 12.5% to 21.9%.

The Role of Geography and Habitat

The risk of infection isn’t just about *what* the animal is, but *where* it lives. For red foxes, the environment plays a critical role in viral exposure:

  • Water Access: Foxes located near the Baltic Sea, bay coasts, or watercourses (such as streams, rivers, and canals) face a significantly higher risk of testing positive for H5 antibodies.
  • Habitat Buffers: Interestingly, a high proportion of shrubland within a 2.5-km buffer zone appears to act as a protective factor, likely by reducing exposure to water-associated hosts like Anseriformes (waterfowl).
  • The Age Factor: Exposure increases over time. In studied fox populations, adult foxes showed a seropositivity rate of 23.5%, compared to 11.6% in juveniles.

For more on how environmental factors influence disease spread, explore our guide on One Health and Ecosystem Management.

The “Mixing Vessel” Risk: Wild Boars and Viral Evolution

Event-Based Surveillance for Early Detection of Emerging Threats

One of the most critical findings for future pandemic preparedness is the role of the wild boar (Sus scrofa). While not primary predators, wild boars are omnivores and known “nest robbers” of waterfowl in wetland areas. Recent surveillance found that 3.5% of wild boars in specific water-associated zones were seropositive for H5. While this percentage is lower than that of carnivores, the implications are far more serious. Suidae species are considered “mixing vessels”—animals that can be infected by swine-, human-, and avian-derived influenza viruses simultaneously. When different virus strains inhabit the same host, they can swap genetic material. This process could potentially lead to the emergence of a new strain that is more easily transmissible among mammals or humans.

Pro Tip for Wildlife Observers: If you encounter dead wildlife in wetland areas, avoid direct contact. Report sightings to local veterinary or environmental authorities to help maintain critical surveillance data.

Future Outlook: From Wildlife to Our Doorsteps

The transition of HPAIV H5 into a perpetual enzootic state means that the risk of spillover is constant. The focus of surveillance is now expanding beyond wild game to include “bridge” animals—pets that move between wild habitats and human households. Free-ranging cats and hunting dogs are primary candidates for this bridge. A dog returning from a hunt or a cat stalking birds in a backyard can bring the virus from a wetland hotspot directly into a home. The future of preventing a mammalian pandemic relies on an “Integrated One Health” approach. This means combining the expertise of veterinarians, environmental scientists, and human physicians to monitor the interface where humans, animals, and the environment meet.

Learn more about the One Health approach to understand how multidisciplinary research prevents the next outbreak.

Frequently Asked Questions

What is a “spillover event” in the context of H5?

A spillover event occurs when a virus that typically circulates in one species (in this case, wild birds) jumps to a different species (such as a fox, boar, or human).

Frequently Asked Questions
Carnivores Avian Influenza

Why are wild boars called “mixing vessels”?

Wild boars can be susceptible to multiple types of influenza viruses (avian, swine, and human). This allows different strains to mix and potentially mutate into new, more dangerous variants.

Are all mammals at risk of H5 avian influenza?

While many species are susceptible, the risk varies. Carnivores and omnivores that eat birds or live in wetlands are at much higher risk than herbivores like deer.

How does the environment affect the spread of H5?

Proximity to water is a major driver. Animals living near coasts, rivers, or marshes have more frequent contact with reservoir hosts like waterfowl, increasing their chance of infection.


Join the Conversation: Do you think current wildlife surveillance is enough to protect public health? Share your thoughts in the comments below or subscribe to our newsletter for the latest updates on zoonotic disease research.

April 28, 2026 0 comments
0 FacebookTwitterPinterestEmail
Health

Maryland reports 2 more measles tied to Baltimore-area residents

by Chief Editor April 25, 2026
written by Chief Editor

The Resurgence of Preventable Diseases: Understanding the Current Trends

Public health officials are seeing a worrying pattern as preventable diseases, such as measles, reappear in communities. While high overall vaccination rates provide a strong shield, recent data indicates that “pockets” of lower immunity are creating vulnerabilities. In Maryland, for example, health officials recently confirmed two additional cases among Baltimore-area residents, bringing the state’s total for the year to three.

View this post on Instagram about Maryland, Public
From Instagram — related to Maryland, Public

These cases highlight a broader national trend, with close to 1,800 reported infections across multiple states this year. The resurgence isn’t random; it is closely tied to shifts in travel patterns and the spread of health-related misinformation.

Did you understand? Measles is incredibly contagious because it spreads through the air. An infected person’s cough or sneeze can leave the virus lingering in a space for up to two hours after they have already left the area.

The Role of Travel in Modern Outbreaks

In an interconnected world, a local outbreak is often the result of global or interstate movement. The most recent cases in Maryland were specifically linked to residents who had traveled to other states where measles transmission was already active.

This trend suggests that public health monitoring must extend beyond local borders. When individuals travel from areas with high transmission to regions with “immunity gaps,” the risk of a localized outbreak increases significantly, regardless of the state’s general health standing.

Confronting the Misinformation Crisis

One of the most significant challenges facing modern medicine is the rise of vaccine misinformation and disinformation. While Maryland has maintained a high vaccination rate—with more than 96% of kindergartners receiving two doses before the last school year—rates have begun to tick down in specific pockets.

These small drops in coverage can be dangerous. When vaccination rates fall below a certain threshold in a specific neighborhood or community, “herd immunity” weakens, allowing a single imported case to spark a wider outbreak. This makes targeted community outreach and the dissemination of evidence-based facts more critical than ever.

Pro Tip: If you suspect you have been exposed to measles, do not go directly to a doctor’s office or emergency room. Contact your healthcare provider first to prevent potentially exposing other patients in the waiting room.

Protecting the Community: The Science of Prevention

The primary defense against these outbreaks remains the measles-mumps-rubella (MMR) vaccine, which experts describe as highly effective. Maintaining high vaccination levels is the only way to ensure that those who cannot be vaccinated for medical reasons remain protected.

Two more cases of measles confirmed in Maryland

For those unsure of their status, reviewing medical records or consulting a physician is the first step. Access to these vaccines is widely available; they are covered by insurance, and those who are uninsured or underinsured can access them through the Vaccines for Children Program or via a local health department.

Recognizing the Signs and Taking Action

Early detection is key to stopping the spread. Symptoms typically appear one to three weeks after exposure and include:

Recognizing the Signs and Taking Action
Public Maryland
  • High fever
  • Running nose
  • Cough
  • A telltale red body rash that spreads from head to toe

Because individuals are contagious four days before and four days after the rash develops, isolation is mandatory. Those exposed are advised to stay home from work and school for three weeks to prevent further community transmission.

Public health departments are now utilizing highly detailed exposure lists—including specific times and locations like grocery stores, cafes, and professional buildings—to identify and notify at-risk individuals quickly. You can learn more about public health safety measures to stay protected.

Frequently Asked Questions

How does measles spread?

It is an airborne virus spread through coughing or sneezing. It can remain active in the air for up to two hours after an infected person leaves the room.

What should I do if I’ve been exposed?

Monitor for symptoms for one to three weeks. If you are exposed, you should stay home from work or school for three weeks and call your doctor before visiting a clinic.

Is the MMR vaccine effective?

Yes, experts state that the measles-mumps-rubella vaccine is highly effective at preventing the disease.

Where can I receive a vaccine if I don’t have insurance?

Uninsured or underinsured individuals can obtain vaccines through the Vaccines for Children Program or their local health department.


Stay Informed: Have you checked your vaccination records recently? Protecting yourself helps protect your entire community. Share this article with your neighbors or leave a comment below to discuss how your community is handling public health awareness.

April 25, 2026 0 comments
0 FacebookTwitterPinterestEmail
Health

CDC detects new COVID-19 variant across 25 US states via wastewater samples

by Chief Editor March 25, 2026
written by Chief Editor

New COVID Variant BA.3.2 Spreading: What You Demand to Know

A new variant of COVID-19 is circulating in the U.S. And globally, prompting health officials to monitor its spread and characteristics. The SARS-CoV-2 BA.3.2 variant has been reported in at least 23 countries as of February 11, according to a recent study by the Centers for Disease Control and Prevention (CDC).

Understanding the BA.3.2 Variant

The BA.3.2 variant is genetically distinct from previous strains like JN.1, LP.8.1, and XFG that dominated infections since January 2024. It possesses approximately 70 to 75 changes in its spike protein – the part of the virus that allows it to enter human cells. This significant number of mutations is a key factor driving concern among researchers.

First confirmed in the U.S. In June 2025, after being detected in a traveler arriving from the Netherlands, BA.3.2 began to rise in prevalence starting in September 2025. From November 2025 to January 2026, weekly detections reached around 30% of cases in Denmark, Germany, and the Netherlands.

Immune Escape and Potential Impact

The CDC has identified “immune escape characteristics” in BA.3.2. This means the mutations in the variant may allow it to partially evade immunity gained from prior COVID-19 infections or vaccinations. While this could lead to more infections, experts currently believe it doesn’t necessarily translate to more severe illness.

The CDC’s advisory panel recently shifted COVID vaccine guidance toward “individual decision-making,” encouraging patients to discuss vaccination with their doctors. This approach keeps shots covered under major insurance programs.

Detection and Surveillance

As of the CDC’s Morbidity and Mortality Weekly Report, BA.3.2 has been detected in the U.S. Through various surveillance methods: nasal swabs from four travelers, clinical samples from five patients, three airplane wastewater samples, and 132 wastewater surveillance samples collected from 25 states.

Researchers emphasize the importance of ongoing genomic surveillance to track the virus’s evolution and assess its potential impact on public health. The prevalence of BA.3.2 may be underestimated due to limited genomic detection and surveillance capabilities in many countries.

Ongoing Viral Evolution

Two sublineages of BA.3.2, BA.3.2.1 and BA.3.2.2, have been identified, indicating continued viral evolution. This highlights the virus’s ability to adapt and change over time.

Frequently Asked Questions

Q: Does the BA.3.2 variant cause more severe illness?
Currently, there is no evidence to suggest that BA.3.2 causes more severe illness than previous variants, but ongoing monitoring is crucial.

Q: Are existing COVID-19 vaccines effective against BA.3.2?
The variant’s immune escape characteristics suggest vaccines may be less effective at preventing infection, but they still offer protection against severe illness.

Q: What can I do to protect myself?
Staying up-to-date with vaccinations, practicing good hygiene (handwashing), and considering masking in crowded indoor spaces are recommended preventative measures.

Q: Where can I find more information about COVID-19 variants?
Visit the Fox News Coronavirus section or the CDC website for the latest updates.

Pro Tip: Wastewater surveillance is a valuable tool for tracking the spread of COVID-19 and identifying new variants, even in areas with limited individual testing.

Stay informed and consult with your healthcare provider for personalized advice on protecting yourself and your family.

Explore more health news on Fox News.

March 25, 2026 0 comments
0 FacebookTwitterPinterestEmail
Health

Seaweed Fucoidan Could Block Norovirus Infection

by Chief Editor March 18, 2026
written by Chief Editor

Seaweed’s Surprising Potential: A Natural Shield Against Norovirus?

For millions worldwide, norovirus – often called the “winter vomiting bug” – is an unwelcome guest, causing widespread outbreaks of gastroenteritis. With over 685 million infections reported annually and no approved vaccines or antiviral treatments currently available, the search for effective prevention strategies has been ongoing. Now, groundbreaking research suggests a surprising ally in this fight: seaweed.

How Seaweed Could Block Infection

Collaborative research between Griffith University in Australia and biotechnology company Marinova has revealed that compounds found in certain seaweeds may act as a physical barrier against norovirus infection. The key lies in how noroviruses infect the body. They attach to molecules in the intestine called histo-blood group antigens (HBGAs).

Researchers tested two seaweed compounds, fucoidan and ulvan, to determine their ability to prevent norovirus from binding to human saliva samples containing HBGAs. Fucoidan, derived from brown seaweed, demonstrated the most promising results, consistently blocking activity against two major norovirus strains: GII.4 and GII.17. The fucoidan appears to bind to the HBGA binding pocket, essentially creating a shield that makes it harder for the virus to attach and infect cells.

Fucoidan: A Familiar Compound with New Promise

Fucoidan isn’t a new discovery. It has a history of use in dietary supplements and has shown good tolerability in human studies. Associate Professor Thomas Haselhorst, a co-senior author of the study, highlighted that this existing safety profile is a significant advantage. “Our study highlights that fucoidan could be a promising, natural treatment for preventing norovirus infection,” he stated.

Did you know? Norovirus is highly contagious and a leading cause of gastroenteritis, characterized by symptoms like nausea, vomiting, diarrhea, fever, stomach pain, headache and muscle aches.

Future Directions: Formulating for Maximum Impact

Even as the initial findings are encouraging, researchers are now focused on optimizing how fucoidan can be formulated to maximize its protective effect within the gastrointestinal tract. This includes exploring different delivery methods and dosages to ensure optimal efficacy.

Beyond Prevention: A Potential Boost for Vaccine Development

The research doesn’t just offer a potential preventative measure; it could also inform the development of future vaccines. A related study, highlighted by BioTechniques, focuses on creating a system to better understand how norovirus genes function, potentially opening new avenues for antiviral development and vaccine creation.

The Rise of Marine-Derived Pharmaceuticals

This research is part of a growing trend of exploring marine environments for pharmaceutical solutions. Seaweed, in particular, is attracting attention due to its rich source of bioactive compounds with potential health benefits. The relatively untapped biodiversity of the ocean represents a vast resource for discovering novel treatments for a range of diseases.

Pro Tip:

While fucoidan shows promise, it’s important to remember that this research is ongoing. Consult with a healthcare professional before making any significant changes to your diet or supplement regimen.

Frequently Asked Questions

Q: What is norovirus?
A: Norovirus is a highly contagious virus that causes gastroenteritis, leading to vomiting and diarrhea.

Q: Is there a vaccine for norovirus?
A: Currently, there are no approved vaccines for norovirus.

Q: What is fucoidan?
A: Fucoidan is a compound found in brown seaweed that has shown potential in blocking norovirus infection.

Q: Is fucoidan safe?
A: Fucoidan has a history of dietary use and has demonstrated good tolerability in human studies.

Q: Where can I find fucoidan supplements?
A: Fucoidan is available in some premium dietary supplements. Always consult with a healthcare professional before starting any new supplement.

Want to learn more about the latest breakthroughs in health and wellness? Subscribe to our newsletter for regular updates and expert insights.

March 18, 2026 0 comments
0 FacebookTwitterPinterestEmail
Health

Bird Flu: Black Vultures Hit Hard – New Study & Mutation Risk

by Chief Editor March 18, 2026
written by Chief Editor

Black Vulture Die-Off Signals Wider Bird Flu Threat

A concerning new study from the University of Georgia reveals that black vultures are being decimated by highly pathogenic avian influenza (H5N1), commonly known as bird flu. More than 84% of 134 deceased black vultures examined across seven Southeastern states tested positive for the virus in 2022 and 2023, raising alarms about the potential for increased mutation and spread to other species.

A Year-Round Cycle of Disease

Unlike typical bird flu seasons, black vultures’ scavenging habits appear to be sustaining the virus year-round. Researchers observed vultures consuming the carcasses of infected birds, creating a dangerous feedback loop. “Every day, more carcasses would appear, and we could notice that the black vultures were eating their dead cohorts,” explained Dr. Nicole Nemeth, lead author of the study and head of UGA’s Southeastern Cooperative Wildlife Disease Study. “From a survival perspective, that’s smart. It’s a ready-made, available food source. But it perpetuates this cycle of disease within the vulture population year-round.”

Mutation Concerns and the Human Risk

The sustained transmission of H5N1 is particularly worrisome as it increases the opportunities for the virus to mutate. While there is currently no evidence of the virus jumping to humans via the vulture population, the potential remains a significant concern. “This virus is scary. It’s changing. And it’s doing continual damage to our wildlife—on top of all the other challenges these wildlife already face,” Nemeth stated.

Ecological Impact Beyond Vultures

Black vultures play a crucial ecological role by removing carcasses that could spread disease. A decline in vulture populations could lead to an increase in disease transmission to other animals and even humans. “In areas where vulture populations have been diminished, there are a lot more dead animals left in the landscape, which actually has been shown to contribute to increased diseases in people, wildlife, and domestic animals,” Nemeth noted.

Vulnerability Across Species

While black vultures are relatively abundant, the study highlights the vulnerability of other bird species with smaller populations. A 2023 outbreak of bird flu among California condors, for example, resulted in the deaths of at least 20 birds – a devastating loss for a species with fewer than 600 individuals remaining.

Resilience and Future Outlook

Despite the high mortality rate, research suggests that approximately half of the black vultures exposed to avian influenza survive, developing antibodies that may offer some protection against future outbreaks. This indicates a degree of resilience within the population. However, researchers emphasize the ongoing diversity of avian influenza viruses and the potential for new, more virulent strains to emerge.

“Avian influenza is incredibly diverse. These highly pathogenic viruses continue to circulate and mix up, and it’s creating a huge potential diversity of different viruses, many of which wildlife species in North America may not have seen before,” said Rebecca Poulson, a coauthor of the study.

Bird Flu’s Expanding Host Range

Originally detected in the 1990s, H5N1 has periodically caused outbreaks in wild and domesticated birds. More recently, the virus has been detected in a wider range of animals, including dairy cows, house cats, dolphins, and bears, raising concerns about its potential for broader transmission.

Frequently Asked Questions

  • What is avian influenza (bird flu)? Avian influenza is a highly contagious viral disease that affects birds, and can sometimes spread to other animals.
  • Are humans at risk from this outbreak? Currently, there is no evidence of the virus spreading to humans from the vulture population, but the potential for mutation remains a concern.
  • Why are black vultures particularly affected? Their scavenging behavior leads to frequent exposure to the virus, creating a year-round cycle of transmission.
  • What is being done to monitor the situation? Researchers at the University of Georgia are continuing to monitor the spread of the virus in wildlife populations.

Pro Tip: Reporting any unusual bird deaths to your local wildlife authorities can facilitate track the spread of avian influenza and protect vulnerable species.

Learn more about avian influenza and its impact on wildlife by visiting the University of Georgia News website.

March 18, 2026 0 comments
0 FacebookTwitterPinterestEmail
Health

130 Children Exposed at Education Center

by Chief Editor March 9, 2026
written by Chief Editor

Measles Cases Rise in Sacramento Region: A Growing Concern

Sacramento County public health officials are responding to a potential measles outbreak after more than 100 children were possibly exposed at an educational enrichment program. The incident highlights a concerning trend of increasing measles cases, not only locally but across the state and nation.

Exposure and Current Cases

The recent exposure occurred when an unvaccinated child who was infectious attended the program in Sacramento County. Health officials are currently tracing contacts, with as many as 130 children potentially affected. As of March 6, at least six cases of measles have been confirmed in Sacramento and neighboring Placer County. One of the infected children received treatment at Kaiser Permanente Roseville Medical Center, prompting a contact tracing effort among patients and staff who were present on March 2.

The Danger of Measles

Dr. Erica Pan, CDPH Director and State Public Health Officer, emphasized the severity of measles, stating it is “one of the most contagious infections” and can lead to “severe life-long consequences including permanent brain damage and can also be fatal, especially for children.” The highly contagious nature of the virus means it can remain suspended in the air for up to two hours in a room, even without direct contact with an infected person.

Link to South Carolina Outbreak

At least one case in Placer County has been linked to travel to South Carolina, where a large outbreak has already been confirmed with over 1,100 cases. This underscores the risk of importing measles from areas experiencing outbreaks.

Vaccination: The Best Defense

Public health officials are strongly urging individuals to check their immunization status and get vaccinated with the measles-mumps-rubella (MMR) vaccine. The MMR vaccine is considered safe and provides long-lasting protection against measles. Vaccination not only protects individuals but also contributes to community immunity, safeguarding those too young to be vaccinated or with compromised immune systems.

What to Expect if Infected

Symptoms of measles can initially resemble a cold. After one to three weeks, a splotchy rash typically develops on the face and spreads down the body. Individuals can be infectious up to four days before symptoms appear, making early detection and isolation crucial.

Frequently Asked Questions

What are the symptoms of measles?

Symptoms include fever, cough, runny nose, and a rash that typically appears on the face and spreads downward.

How can I protect myself and my family?

The most effective way to protect yourself and your family is to get vaccinated with the MMR vaccine.

What should I do if I think I’ve been exposed to measles?

Contact your healthcare provider immediately and inform them of your potential exposure.

Pro Tip: Maintain your vaccination records readily available for quick reference. If you’re unsure of your vaccination status, contact your healthcare provider.

Learn more about measles and vaccination from the California Department of Public Health.

Have questions about the recent measles cases? Share your thoughts in the comments below!

March 9, 2026 0 comments
0 FacebookTwitterPinterestEmail
Health

Early Release – Tuberculosis after TB Preventive Therapy in Persons Living with HIV Recently Initiating Antiretroviral Therapy, Mozambique – Volume 32, Number 3—March 2026 – Emerging Infectious Diseases journal

by Chief Editor February 26, 2026
written by Chief Editor

Mozambique’s Fight Against Tuberculosis: Progress, Challenges, and Future Strategies

Tuberculosis (TB) remains a significant public health threat, particularly for individuals living with HIV. In Mozambique, substantial progress has been made in expanding TB preventive therapy (TPT) among people newly initiating antiretroviral therapy (ART), reaching 89% coverage by March 2024. However, recent data reveals persistent challenges and highlights the need for targeted interventions to further reduce TB incidence.

The Impact of TPT: A National Success Story

Since 2007, Mozambique has prioritized TPT as a key strategy to combat TB among people living with HIV. The introduction of a 3-month course of isoniazid and rifapentine (3HP) in 2023, alongside the traditional 6-month isoniazid regimen, has further bolstered these efforts. A recent analysis of national data from 2021-2022 demonstrates a clear link between TPT completion and reduced TB incidence. Individuals who completed TPT experienced a significantly lower rate of TB diagnosis compared to those who did not start or incompletely finished the therapy.

Specifically, the incidence of diagnosed TB was 3.1 per 1,000 person-years among those who completed TPT, compared to 21.6 per 1,000 person-years for those who didn’t start TPT and 11.0 per 1,000 person-years for those with incomplete TPT. This underscores the critical role of ensuring patients adhere to and complete their TPT regimens.

Uneven Progress: Identifying Vulnerable Populations

Despite the overall success of TPT programs, certain populations remain disproportionately affected by TB. The data reveals higher TB incidence rates among men, younger individuals (<15 years), older individuals (>50 years), and those with poorer clinical status at the start of ART – including unsuppressed viral loads, low CD4 counts, and advanced WHO clinical staging (stages II-IV). Individuals in the Southern Region of Mozambique also exhibited elevated TB rates, potentially linked to regional variations in TB services and case detection.

Pro Tip: Targeted interventions focusing on these vulnerable groups are crucial for maximizing the impact of TPT programs. This includes tailored outreach, adherence support, and addressing underlying health factors.

The Future of TPT: Exploring New Approaches

While TPT has proven effective, ongoing research is exploring potential refinements to the strategy. The question of whether a second course of TPT would provide additional benefit for those who complete an initial regimen remains a subject of debate. A recent randomized controlled trial in Ethiopia, Mozambique, and South Africa did not demonstrate a significant advantage from a repeat course of 3HP. However, further investigation may be warranted for specific high-risk individuals.

Enhancing data quality and leveraging national data warehouses, like Mozambique’s MozART system, are also essential for monitoring program effectiveness and identifying areas for improvement. Continued investment in surveillance, testing, and outbreak preparedness, in collaboration with organizations like the CDC and USAID, will be vital for sustaining progress.

Strengthening Health Systems for Long-Term Impact

The success of Mozambique’s TB control efforts is inextricably linked to the strength of its overall health system. Support for the National Tuberculosis Control Program (PNCT) and the National Institute of Health (INS) network of TB reference laboratories, as well as training for public health professionals, are critical components of a sustainable response. Strengthening electronic health and laboratory information systems will further enhance data-driven decision-making and improve patient care.

Did you know? Mozambique closed its wild poliovirus outbreak in 2024, demonstrating the power of collaborative public health initiatives.

Frequently Asked Questions

Q: What is TPT?
A: TPT stands for TB preventive therapy. It’s a medication regimen given to people with HIV to prevent them from developing active TB disease.

Q: Why is TPT important for people with HIV?
A: People living with HIV are significantly more likely to develop TB. TPT reduces this risk and can save lives.

Q: What are the challenges to TPT implementation?
A: Challenges include ensuring patients start and complete the full course of therapy, reaching vulnerable populations, and maintaining data quality.

Q: What is MozART?
A: MozART is Mozambique’s national ART data warehouse, containing clinical data from over 1.6 million people living with HIV.

This ongoing commitment to collaboration, data-driven strategies, and targeted interventions will be essential for achieving epidemic control of TB and protecting the health of the Mozambican population.

February 26, 2026 0 comments
0 FacebookTwitterPinterestEmail
Newer Posts
Older Posts

Recent Posts

  • Two Boys Given Conditional Warnings for MRT Train Break-in

    June 30, 2026
  • Aimen Horch Denounces Fake News and Intimidation After Arrest

    June 30, 2026
  • No One Will Marry Her

    June 30, 2026
  • Claudia Liptai Removes Breast Implants

    June 30, 2026
  • Slovácko Announces Legend’s Return to Bolster Sporting Department

    June 30, 2026

Popular Posts

  • 1

    Maya Jama flaunts her taut midriff in a white crop top and denim jeans during holiday as she shares New York pub crawl story

    April 5, 2025
  • 2

    Saar-Unternehmen hoffen auf tiefgreifende Reformen

    March 26, 2025
  • 3

    Marta Daddato: vita e racconti tra YouTube e podcast

    April 7, 2025
  • 4

    Unlocking Success: Why the FPÖ Could Outperform Projections and Transform Austria’s Political Landscape

    April 26, 2025
  • 5

    Mecimapro Apologizes for DAY6 Concert Chaos: Understanding the Controversy

    May 6, 2025

Follow Me

Follow Me
  • Cookie Policy
  • CORRECTIONS POLICY
  • PRIVACY POLICY
  • TERMS OF SERVICE

© 2026 Newsy Today. All rights reserved.
For contact, advertising, copyright, issues email: [email protected]


Back To Top
Newsy Today
  • Business
  • Entertainment
  • Health
  • News
  • Sport
  • Tech
  • World